Bayer Closes Frankfurt Site, Sparks “Turning Point” for Works Council
- Facing intense global price competition,Bayer AG plans to shutter its Frankfurt am Main location by the end of 2028,impacting approximately 500 employees.
- The DAX-listed company aims to consolidate its agricultural operations, focusing on strategic, innovative technologies to better compete with lower-priced generic pesticides, especially from Asian manufacturers.
- Research and development activities currently conducted in Frankfurt will be centralized at the Monheim am Rhein site.
bayer to Close Frankfurt Site,citing Cost Pressures
Table of Contents
- bayer to Close Frankfurt Site,citing Cost Pressures
- Bayer to Close Frankfurt Site: Answering Your Questions
- Why is Bayer Closing its Frankfurt Site?
- What Specific Operations Will Be shut Down?
- When is the Frankfurt Site Expected to close?
- How Many Employees Will Be Affected?
- Where will Research and Development Activities Be Relocated?
- What Other Locations will Be Impacted by the Restructuring?
- How Many Positions are Being Eliminated at dormagen?
- What is the Total Workforce at the Dormagen Facility?
- Why is Bayer Restructuring its Crop Science Division?
- What Role Does Asian Competition Play in This Decision?
- Is Bayer Seeking a Buyer for the Frankfurt Site?
- How Has the Closure Been Received?
- Key Takeaways Summarized
- A Closer Look at Bayer’s Restructuring: Key facts
Facing intense global price competition,Bayer AG plans to shutter its Frankfurt am Main location by the end of 2028,impacting approximately 500 employees. The move is part of a broader restructuring effort within the pharmaceutical and agrochemical giant’s crop science division.
The DAX-listed company aims to consolidate its agricultural operations, focusing on strategic, innovative technologies to better compete with lower-priced generic pesticides, especially from Asian manufacturers. Bayer’s decision reflects increasing cost pressures and regulatory challenges, according to a company statement.
Research and development activities currently conducted in Frankfurt will be centralized at the Monheim am Rhein site. Additionally, production adjustments at the Dormagen location near Leverkusen are expected to result in the elimination of around 200 positions. Approximately 1,200 people are currently employed at the Dormagen facility.
While Bayer intends to discontinue operations in Frankfurt,which include both herbicide production and pesticide research,the company stated that it is seeking a buyer for portions of the production capacity. Other operations will be transferred to Bayer’s facilities in dormagen and Knapsack, located in Hürth near Cologne.
According to Bayer, the rise of Asian pesticide manufacturers with notable overcapacity has led to sustained low prices, sometiems below European production costs. This competitive landscape has forced the company to reassess its operational footprint.
The planned closure has drawn strong criticism from labor representatives. Francesco Grioli, a board member of the chemical union IG BCE, called the decision “a turning point in the 162-year history of the group,” adding that it “contradicts the declared Bayer Creed on Germany.”
The union and the general works council emphasized that abandoning the Frankfurt location would be unprecedented for Bayer in Germany. They are urging the company to explore alternatives to a complete shutdown.
Bayer to Close Frankfurt Site: Answering Your Questions
Why is Bayer Closing its Frankfurt Site?
Bayer AG is closing its Frankfurt am Main location due to intense global price competition and cost pressures. The company aims to consolidate its agricultural operations within its crop science division.
What Specific Operations Will Be shut Down?
The closure involves herbicide production and pesticide research currently conducted at the Frankfurt site.
When is the Frankfurt Site Expected to close?
Bayer plans to shutter the Frankfurt location by the end of 2028.
How Many Employees Will Be Affected?
Approximately 500 employees are expected to be impacted by the closure of the Frankfurt site.
Where will Research and Development Activities Be Relocated?
Research and development activities currently conducted in Frankfurt will be centralized at the Monheim am Rhein site.
What Other Locations will Be Impacted by the Restructuring?
Production adjustments at the Dormagen location near Leverkusen are also planned. Additionally, some operations will be transferred to BayerS facilities in Dormagen and Knapsack, which is near Cologne.
How Many Positions are Being Eliminated at dormagen?
Around 200 positions are expected to be eliminated at the Dormagen facility as part of the restructuring.
What is the Total Workforce at the Dormagen Facility?
Approximately 1,200 people are currently employed at the dormagen facility.
Why is Bayer Restructuring its Crop Science Division?
Bayer aims to consolidate its operations to focus on strategic, innovative technologies to better compete with lower-priced generic pesticides, especially those from Asian manufacturers.They are also facing increasing cost pressures and regulatory challenges.
What Role Does Asian Competition Play in This Decision?
According to Bayer, the rise of Asian pesticide manufacturers, leading to overcapacity and sustained low prices (sometimes below European production costs), has forced the company to reassess its operational footprint.
Is Bayer Seeking a Buyer for the Frankfurt Site?
While Bayer intends to discontinue operations in Frankfurt, the company is seeking a buyer for portions of its production capacity.
How Has the Closure Been Received?
The planned closure has drawn strong criticism from labor representatives. Francesco Grioli, a board member of the chemical union IG BCE, called the decision “a turning point in the 162-year history of the group.” The union and general works council are urging the company to explore alternatives to a complete shutdown, emphasizing that abandoning the Frankfurt location would be unprecedented for Bayer in Germany.
Key Takeaways Summarized
Here’s a quick summary of the key points:
Closure: Frankfurt am Main site by the end of 2028.
Reason: Intense global price competition and rising costs.
Impact: Approximately 500 employees and R&D relocation to Monheim am Rhein.
Dormagen: Production adjustments, elimination of around 200 positions.
Competition: Focus on competing with lower-priced generic pesticides from Asian manufacturers.
Criticism: Strong opposition from labor unions.
A Closer Look at Bayer’s Restructuring: Key facts
| Feature | Details |
| ————————- | ——————————————————————————————————– |
| Location Closing | Frankfurt am Main |
| Target Completion Date | End of 2028 |
| Affected Employees | ~500 |
| Reason for Closure | Intense global price competition, cost pressures, and regulatory challenges |
| Relocated R&D | Monheim am Rhein |
| dormagen Impact | Production adjustments and ~200 job cuts |
| Asian Competition | Rise of Asian pesticide manufacturers with overcapacity leading to low prices |
| Union Response | Strong criticism, seeking alternatives to a complete shutdown; “a turning point in the 162-year history” |